Baird Financial Group
SRNE

Baird Financial Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Baird Financial Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-162,275
Closed -$1.26M – 1274
2016
Q3 		$1.26M Sell
162,275
-48,502
-23% -$327K 0.01% 693
2016
Q2 		$1.18M Sell
210,777
-50,171
-19% -$321K 0.01% 690
2016
Q1 		$1.4M Buy
260,948
+5,737
+2% +$33.3K 0.01% 624
2015
Q4 		$2.22M Sell
255,211
-15,014
-6% -$127K 0.02% 503
2015
Q3 		$2.27M Sell
270,225
-35,566
-12% -$567K 0.02% 481
2015
Q2 		$5.39M Buy
+305,791
New +$3.93M 0.05% 318

Other funds holding SRNE

WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return